UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051859
Receipt number R000059076
Scientific Title Accuracy of predicted plasma concentration of fentanyl in children
Date of disclosure of the study information 2023/08/10
Last modified on 2024/02/07 12:59:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Accuracy of predicted plasma concentration of fentanyl in children

Acronym

Accuracy of predicted plasma concentration of fentanyl in children

Scientific Title

Accuracy of predicted plasma concentration of fentanyl in children

Scientific Title:Acronym

Accuracy of predicted plasma concentration of fentanyl in children

Region

Japan


Condition

Condition

Pediatric patients 0-15 years of age undergoing general anesthesia

Classification by specialty

Anesthesiology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will measure blood concentrations of fentanyl in pediatric patients, including neonates, and compare them with predicted concentrations from existing fentanyl pharmacokinetic models to confirm the accuracy of the predictions.
If there is a large discrepancy between the measured values and the predictions by the existing model, we will attempt to correct the existing pharmacokinetic model using the measured values from this study.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Predictive Accuracy of Existing Fentanyl Pharmacokinetic Models.

Key secondary outcomes

Consider whether or not a corrected pharmacokinetic model is required.
If necessary, a corrected pharmacokinetic model will be created.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

Pediatric patients from 0 to 15 years old undergoing general anesthesia at Chiba Children's Hospital.
Patients who will have arterial pressure lines secured during surgery.
Patients who will be admitted to the ICU or NICU after surgery.
Patients who can continue to have blood drawn from the arterial pressure line after admission.

Key exclusion criteria

Patients on cardiopulmonary bypass
Patients with liver dysfunction
Patients with renal impairment
Patients with metabolic disorders

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Mariko
Middle name
Last name Hara

Organization

Chiba Children's Hospital

Division name

Department of Anesthesiology

Zip code

2660007

Address

579-1 Heda-cho, Midori-ku, Chiba-shi, Chiba

TEL

0432922111

Email

mhara@room.ocn.ne.jp


Public contact

Name of contact person

1st name Mariko
Middle name
Last name Hara

Organization

Chiba Children's Hospital

Division name

Department of Anesthesiology

Zip code

266-0007

Address

579-1 Heda-cho, Midori-ku, Chiba-shi, Chiba

TEL

0432922111

Homepage URL


Email

mhara@room.ocn.ne.jp


Sponsor or person

Institute

Chiba Children's Hospital

Institute

Department

Personal name

Mariko Hara


Funding Source

Organization

Terumo Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba Children's Hospital Ethics Committee

Address

579-1 Heda-cho, Midori-ku, Chiba-shi, Chiba

Tel

0432922111

Email

kodomo_ijikei@mz.pref.chiba.lg.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 05 Month 23 Day

Date of IRB

2023 Year 05 Month 23 Day

Anticipated trial start date

2023 Year 08 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Pediatric patients aged 0 to 15 years who received general anesthesia at Chiba Children's Hospital from August 9, 2023 will be included in the study.
Fentanyl will be administered intraoperatively and the residual fentanyl concentration will be measured postoperatively.
The measured fentanyl concentrations will be compared with predicted concentrations calculated from existing pharmacokinetic models.


Management information

Registered date

2023 Year 08 Month 08 Day

Last modified on

2024 Year 02 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059076


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name